Long COVID wearable study to track symptoms and help daily management
Part of Bones, joints & muscles, Brain & nervous system, Infections, Lungs & breathing clinical trials.
This study uses a wearable device to track symptoms and patterns in people with Long COVID, ME/CFS, and/or POTS. The goal is to see how wearable feedback and tracking tools may help you manage your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old.
- Have a diagnosis of Long COVID, ME/CFS, and/or POTS (by your doctor and/or by stated criteria).
- Want to use tools or strategies to manage your Long COVID, ME/CFS, and/or POTS symptoms.
- Own a wearable you can use in the study, or agree to use one provided by the study.
- Be willing to wear it the whole study, sync data at least weekly, and share the data with the study.
- Have a smartphone or tablet to help you sync and view feedback.
- Agree to answer at least 75% of the study surveys.
- Agree to let the study know about other treatments or studies you’re doing for these conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for ME/CFS (chronic fatigue syndrome) that includes symptoms like dizziness when standing. It uses a smartphone app to track your progress and aims to see if the treatment can improve your daily life.
This study looks at people with lingering post-COVID symptoms, especially breathing and lung-related findings, using home monitoring and medical tests. It may help researchers understand what’s driving ongoing symptoms and identify patterns that could guide better care.
This study is testing a new, non-invasive way to diagnose Long COVID using a simple bioelectrical assessment. It might help if you've had COVID-19 and have been dealing with ongoing symptoms for 12 weeks or longer.
This trial tests a program to help people with ongoing fatigue, shortness of breath, or chest pain after COVID-19. It uses a personalized plan to improve your daily function and heart health.
This study is investigating fatigue using digital outcomes in people with multiple sclerosis, long COVID, and healthy volunteers. Participants must own a smartphone, be fluent in German or English, and be willing to provide informed consent. Exclusion criteria include having taken certain medications recently, being pregnant or lactating, or having additional health conditions that could affect fatigue or the autonomic nervous system.
This study uses a digital platform (app/website) to collect lifestyle and symptom information to better understand brain inflammation. You may qualify if you have certain conditions like Long COVID, migraines, autoimmune disease, inflammatory gut issues, mood disorders, or if you are a healthy comparison person.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.